Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Sep 11, 2025, 06:00 ET BizClik Launches September 2025 Editions Across 8 Leading Industry Magazines
Horn discuss unlocking the supply chain's first mile,this issue also spotlights the industry's leading events, from the Gartner Supply Chain Symposium/Xpo to Procurement & Supply Chain LIVE and SAP Connect. Procurement Magazine -This edition offers a preview of Procurement & Supply
More news about: BizClik Media
Sep 10, 2025, 07:00 ET Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis
XPOVIO is a first-in-class, oral exportin 1 (XPO1) inhibitor and the first of Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds for the treatment of cancer. XPOVIO functions by selectively binding to and inhibiting the nuclear export protein XPO1. XPOVIO is approved in the U.S. and marketed
More news about: Karyopharm Therapeutics Inc.